Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Director operating in the Health Care space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Joe Rubino
R&D Director of Reckitt
Follow Joe Rubino:
About Reckitt, Reckitt: Reckitt Benckiser Group is a consumer goods company makes health, hygiene and home products.
_______
Tina Joros
Director of Allscripts
In her role as Director of the Allscripts Developer Program, Tina is constantly organizing, marketing, and managing the sale of new applications and integrations built by her team of developers. This Fall Tina joins Health 20 to demo the numerous new tools that she has introduced to the Allscripts store.
Follow Tina Joros:
About Allscripts: Allscripts provides healthcare information technology solutions.
Lincoln Pasquina
Associate Director, SmartTrials of Foundation Medicine
Lincoln’s first experience with the scientific method was his 7th grade science project on the effects of microwaving plant seeds before planting. (10 seconds on medium makes seeds germinate faster than untreated controls. 30 seconds cooks the seeds.) After graduating from MIT with a major in Biology, he became a graduate student in Suzanne Walker’s lab at Harvard, where he is currently studying bacterial cell wall synthesis and inhibition. He hopes to contribute to the ongoing fight against antibiotic resistance in bacteria.Are you a Harvard graduate student interested in joining our staff? Please email us at questions@emerginginvestigators.org
Follow Lincoln Pasquina:
About Foundation Medicine: Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Varun Gupta
IT Director, Advanced Analytics and Data Management of Mount Sinai Health System
Varun Gupta is a Technology executive with extensive IT Design, Strategy and Leadership experience in delivering business solutions to improve performance, reduce operational expenses and promote organizations growth. Focus areas include Information / Data Architecture and Strategy, Machine learning, Business Intelligence, Digital Solutions, Cloud Frameworks, Database Development and Implementation. Proficient in assisting organizations through Analytics and Digital transformations and setting up Big Data ecosystems and Advanced Analytics platforms for desired outcomes. Worked with Fortune 500 companies and has experience in leading and mentoring teams of Designers and Architects throughout the complete Software Development Life Cycle. Experienced in partnering with Data, Analytics and Digital technology vendors and Technology teams to evaluate Innovative solutions and build data infrastructure and solutions in a phased manner aligned with customers and the business needs. He is an expert in diverse Healthcare IT solution working for both Provider and Payer organizations. Proficient in leading large teams constituting Program managers, Technical Architects and Leads, database engineers and designers. Experienced in Designing state of the art Data as a service Frameworks via self-service API’s, Big Data on Hadoop ecosystem, citizen Business Intelligence solutions and Salesforce Platform. Varun has a bachelors in Computer Engineering and a Masters in Data science and Program Management from UCONN
Follow Varun Gupta:
About Mount Sinai Health System: The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.
Lisa Chase
Senior Director of Marketing & Operations Strategy, Otolaryngology – Head , Neck Surgery of Mount Sinai Health System
Lisa Chase is the Senior Director of Marketing and Operations Strategy, Dept. of Otolaryngology at Mount Sinai Health System.
Follow Lisa Chase:
About Mount Sinai Health System: The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.
Daniel Wilcox
Director of Member Care of Ro
Follow Daniel Wilcox:
About Ro: Ro is a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation.
Romy Hussain
Director of Healthcare Economics & Data Science of Johns Hopkins University School of Medicine
Romy Hussain serves as the Director of Healthcare Economics and Data Science at Johns Hopkins School of Medicine.
Follow Romy Hussain:
About Johns Hopkins University School of Medicine: Johns Hopkins University School of Medicine provides training and education in medical disciplines.
Brian Hasselfeld
Medical Director, Digital Health and Telemedicine of Johns Hopkins University School of Medicine
Mr. Hasselfeld spent three years at Deutsche Bank in New York City as an investment-banking analyst, working on debt, equity and equity-linked financing transactions, as well as mergers and acquisitions. He has participated in over 20 separate financing transactions, raising more than $12 billion for companies in the media and telecommunications sectors. Brian is a current M.D. candidate at Tulane University’s School of Medicine and holds a B.S. in Computer Science, with additional majors in Economics and Mathematics from Vanderbilt University.
Follow Brian Hasselfeld:
About Johns Hopkins University School of Medicine: Johns Hopkins University School of Medicine provides training and education in medical disciplines.
Aaron Watkins
Sr. Director of Internet Strategy & Digital Content Marketing of Johns Hopkins University School of Medicine
Aaron Watkins is the Senior Director of Internet Strategy and Digital Content Marketing at Johns Hopkins Medicine. He leads the Academic Medical Center and health system in a comprehensive online strategy that includes content strategy, internet marketing, social engagement, user experience design and technical development. Previously, Aaron has led enterprise-wide web and application development projects for several medical non-profits, CareFirst BlueCross BlueShield and the National Aquarium in Baltimore, where his team’s work was recognized with a Webby Award. Aaron is a Human Factors certified web usability analyst.
Follow Aaron Watkins:
About Johns Hopkins University School of Medicine: Johns Hopkins University School of Medicine provides training and education in medical disciplines.
Jonathan Dry
Director, Early Oncology of AstraZeneca
Jonathan studied Biomedical Sciences at the University of Manchester where his research focused on the genetics of diabetes, exposing him to the richness of information in DNA that can be uncovered with computational tools. He was awarded a scholarship at the University of Exeter to study Bioinformatics, where he collaborated with GlaxoSmithKline to develop computational models determining the risk of recombinant protein breakdown by proteases in host cells. In 2003 Jonathan joined AstraZeneca as the first member of the newly formed Oncology Bioinformatics team. As a scientist and senior scientist he drove adoption of ‘omic data to establish molecular line of sight for new targets, specializing in gene expression microarrays. He introduced a number of pioneering approaches harnessing gene expression data from cancer cell lines to uncover the mechanisms of pathway/drug target dependency, discovering biomarkers of drug response. Throughout his career he has supported and influenced a number of programs, including drugs targeting PARP (Lynparza), mTOR, PI3K, AKT and ERBB. His work for the MEK inhibitor selumetinib led to a transcriptional readout of MEK activity that became the first transcriptomic hypothesis tested in AZ clinical trials. As a team leader and now Director Jonathan has gone on to build a global group focused on harnessing next generation sequencing and genomic data to further AstraZeneca’s oncology drug programs and precision medicine. His team are recognized as leaders in the field, with a number of high profile publications and algorithms now adopted by leading research centers around the world such as the VarDict NGS variant caller. Jonathan carries a strong collaborative attitude and is a champion of open innovation to harness the world’s data and expertise for actionable discovery.
Follow Jonathan Dry:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Bruce Burlington
Non-Executive Director of AstraZeneca
Bruce Burlington is a prominent independent consultant on pharmaceutical product development and regulatory affairs with more than 30 years of experience in regulatory affairs and drug development. Bruce Burlington’s extensive experience in drug and product development comprises several senior posts at Wyeth, including Executive Vice President and Worldwide Head of Regulatory Affairs, where he played a central role in the development and global registration of many products. Prior to joining Wyeth, Bruce Burlington was a leader at the US Food and Drug Administration (FDA) where he served for 17 years in various roles, including director of the Division of Biological Investigational New Drugs, several management positions in the Center for Drug Evaluation and Research, and director of the Center for Devices and Radiological Health. As an infectious disease physician and a leader in regulatory policy, Bruce Burlington has served as the industry representative on the FDA’s Drug Safety and Risk Management Advisory Committee and currently holds Board positions at Cangene Corporation, AstraZeneca, and the International Partnership for Microbicides. Bruce Burlington graduated from Louisiana Tech University with a B.A. in Psychology and Economics and received his M.D. degree from Louisiana State University. He completed his internal medicine internship and residency, as well as his infectious disease fellowship, at the University of Colorado.
Follow Bruce Burlington:
About : AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
David Reif
Associate Director of Cancer Research of AstraZeneca
Dr. Reif serves as an Associate Director of Cancer Research at AstraZeneca. David received his B.S. in Microbiology from the University of Michigan, and his Ph.D. in 1990 in Biochemistry and Molecular Biology from Utah State University in the laboratory of Dr. Steven Aust. He completed his post-doctoral training with Dr. Roy Simmons at Fisons Pharmaceuticals (a predecessor company to AstraZeneca) in Rochester, NY. Dr. Reif then joined the staff at Fisons where he led drug discovery project teams in the areas of Parkinson’s Disease, ALS, and stroke in addition to leading the biochemistry group. In 2000, he was the first to join a new cancer discovery group within AstraZeneca at their facilities in Waltham. Dr. Reif is currently an Associate Director and Operations Manager within the cancer department and works as a member of the cancer management team in managing the portfolio of novel projects for cancer therapy. David is also intimately involved in many community outreach activities. He is a key liaison for AstraZeneca’s involvement with the New England chapter of the American Cancer Society (Making Strides Against Breast Cancer Walk and the Hope Lodge). He currently serves on the Board of Directors of the National Association of Academies of Science as well as the Massachusetts Biotechnology Education Foundation (the last four as Chairman). He also recently ended 10 yrs of service on the Lunenburg School Committee (7 total years as Chairman). Dr. Reif lives in Lunenburg, MA with his wife Trish and their three children (two in college and one in high school).
Follow David Reif:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Jessica Pfennig
Director of Global Digital Governance of AstraZeneca
Jessica Pfennig is Director of Global Digital Governance at AstraZenica and an impactful global leader and digital innovator with over 20 years of strategy and management experience within large pharmaceutical organizations. Jessica has advanced degrees in chemistry, information science and an EMBA. Jessica is in charge of managing and monitoring AZ’s digital asset estate. In this role she influences the future regulations for digital interactions with patients, physicians and payers. She is recognized for integrating risk avoidance and commercial compliance standards to introduce innovative technology and services. Jessica is also the Senior Global Chair for the Digital Innovators within the Healthcare Businesswomen’s Association.
Follow Jessica Pfennig:
About AstraZeneca, AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Mariam Iqbal
Director Of Procurement of AstraZeneca
Follow Mariam Iqbal:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Neerav P. Padliya
Associate Director, Regulatory Affairs of AstraZeneca
Follow Neerav P. Padliya:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Dawn Timan
Senior Tax Director / Chief Compliance Officer of Norwest Venture Partners
Follow Dawn Timan:
About Norwest Venture Partners: Norwest is a global venture capital and growth equity investment firm that specializes in venture and growth equity companies.
Jeremy Berger
Creative Director of Elysium
Follow Jeremy Berger:
About Elysium: Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.
Ashley Mitchell
Director of Marketing of New Enterprise Associates
Follow Ashley Mitchell:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Shanna Hendriks
Director, Portfolio Services – Business Development of New Enterprise Associates
Shanna joined NEA as a Director, Portfolio Services – Business Development in 2014. She focuses on communications and marketing support for the portfolio which includes supporting the PR needs of early-stage companies, acting as a resource to later-stage companies, and developing educational programs and events at NEA for portfolio companies of all levels of growth. She also supports the portfolio through business development and executive briefings. Shanna brings more than eight years of PR agency work at some of the leading PR agencies in the Bay Area to her role with NEA. She was one of the first hires at LaunchSquad where she learned the ropes of emerging tech PR. She then worked with a boutique firm where she represented some of the most well-known winter sport brands doing consumer PR. Realizing that she missed crafting the story that has become so important for technology companies, she went on to join Hill & Knowlton’s tech practice working with Fortune 500 companies such as Qualcomm, HP, and Yahoo!. Shanna then transitioned in-house to communications at Shutterfly working on corporate communications and the company’s photobooks and share site products. In 2012, Shanna joined Tesla Motors where she among other things, launched Model S, the Supercharger network, and provided comms support to the company’s retail rollout. Shanna moved to the Bay Area from Canada in 2004. Prior to that move, Shanna worked in PR at Ottawa’s famous Fairmont Chateau Laurier. She attended Algonquin College for Public Relations in Ottawa, Ontario.
Follow Shanna Hendriks:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Brian Carlsen
Co-Founder & Director, Clinical Informatics of Ciitizen
Brian Carlsen is a clinical terminologist, previously for Apple Health. An advisory group member of SNOMED, he was an architect of the NLM’s UMLS and the NCI Metathesaurus, designed to help solve for semantically interoperable health records. He’s a software developer of web-based and open source tools for the leveraging of clinical terminologies across healthcare domains including labs and medications. He is an expert in creating computable representations of health data as a consistent way to index, store, retrieve, and aggregate medical data across payers, providers, and consumer devices.
Follow Brian Carlsen:
About Ciitizen: Ciitizen’s mission is empower patients with complete control of their health data.
Dean L. Young
Head of Product and Director of Product Management of AWAIR
Dean L. Young is a Head of Product and Director of Product Management at Awair. He is a former Marketing and Operations Manager at Lark Technologies and Co-Founder of D.C. Revolutions. Mr. Young graduated from Stanford University with a bachelor of science in Environmental Economics.
Follow Dean L. Young:
About AWAIR: Awair’s mission is to empower people worldwide to breathe safely through cutting-edge indoor air quaity monitoring.
Donald Ehrlich
Member of the Board of Directors of Danaher
Donald Ehrlich has served on Danaher’s Board of Directors since 1985. He served as President and Chief Executive Officer of Schwab Corp., a manufacturer of fire-protective safes, files, cabinets and vault doors, from January 2003 to July 2008, and has also served on the boards of private and non-profit organizations. Donald also founded and served as the chairman and chief executive officer of an NYSE-listed, publicly-traded manufacturing company, and has also founded and served as CEO of two privately held manufacturing companies. As an entrepreneur and business leader who began his career on the factory floor, has been awarded over fifteen patents and worked his way to leadership of a large, publicly-traded company, Donald has a broad understanding of the strategic challenges and opportunities facing a publicly-traded manufacturing company such as Danaher. He also has a broad, functional skill-set in the areas of engineering, finance, capital allocation and executive compensation
Follow Donald Ehrlich:
About : Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Walter Lohr
Member of the Board of Directors of Danaher
Walter Lohr has served on Danaher’s Board of Directors since 1983. He was a partner of Hogan Lovells, a global law firm, for over five years until retiring in June 2012 and has also served on the boards of private and non-profit organizations. Prior to his tenure at Hogan Lovells, Walter served as assistant attorney general for the State of Maryland.He has extensive experience advising companies in a broad range of transactional matters, including mergers and acquisitions, contests for corporate control and securities offerings. His extensive knowledge of the legal strategies, issues and dynamics that pertain to mergers and acquisitions and capital raising have been a critical resource for Danaher given the importance of its acquisition program.
Follow Walter Lohr:
About : Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Justin Holland
Senior Director of Danaher
Follow Justin Holland:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Neil Poloso
Executive Director, Biological Research of Allergan
Follow Neil Poloso:
About AbbVie, Allergan: Allergan is a global pharmaceutical company.
Tory Brady
Director of Product Engineering of Allergan
Tory Brady’s passion is building software with a keen eye on the customer and the jobs they’re hiring a product to do in their lives. He loves when beautiful design, performant code and comprehensive data intersect. He’s had a fruitful career as a Software Engineer, working for a variety of technology start-ups. Now Tory is applying these learned start-up methodologies to Allergan’s medical aesthetics business as they work to revitalize the digital relationship with their consumers.
Follow Tory Brady:
About Allergan: Allergan is a global pharmaceutical company.
Vijay Raghavan
Senior Director, Management Science of Allergan
Follow Vijay Raghavan:
About Allergan: Allergan is a global pharmaceutical company.
Amy Tenderich
Editorial Director, Diabetes & Patient Advocacy at Healthline.com of Healthline Media
Follow Amy Tenderich:
About DiabetesMine.com, DiabetesMine.com, Healthline Media: Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
Gregory Hinckley
Lead Director of Bio-Rad Laboratories
Hinckley has been President of the Company since 2000, and was Executive Vice President, Chief Operating Officer and Chief Financial Officer of the Company from 1997 to 2000. He continued to function as the Company’s Chief Financial Officer from 2000 to July 2007, and again became the Chief Financial Officer in December 2008. He is a director of Intermec, Inc. (a provider of integrated system solutions), Super Micro Computer, Inc. (a server board, chassis and server systems supplier), and SI Bone, Inc. (a privately held medical device company). Until 2007, Hinckley was also a director of Amkor Technology, Inc. (a provider of semiconductor packaging and test services). Prior to joining Mentor, Hinckley was Vice President, and then Senior Vice President, of VLSI Technology, Inc. (a semiconductor company) from 1992 to 1997.
Follow Gregory Hinckley:
About Bio-Rad Laboratories: Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of
Bijan Salehizadeh
Founder and Managing Director of NaviMed Capital
Bijan has over 15 years of operational and investment experience in healthcare IT and products. He currently serves as managing director and co-founder at NaviMed Capital, a private investment firm based in Washington, DC where he focuses on growth venture capital healthcare investments in healthcare IT / analytics and healthcare services. Prior to co-founding NaviMed, he was a General Partner at Highland Capital Partners, a multi-billion dollar investment firm where was responsible for leading many of the firm’s healthcare transactions over a decade. Prior to joining Highland in 2003, Bijan spent several years at Medtronic, a global medical products and solutions company. Before Medtronic, he was an early employee at and held a variety of senior management roles at HealthCentral, a venture capital-backed healthcare IT company that went public in 1999. He is currently on the board of directors and advisory committees of numerous healthcare data and products companies including Auris Surgical, Hyperion Therapeutics (IPO), kyruus, and Procured Health, and has sourced or been actively involved in investments in AVEO Oncology (IPO), Baronova, BÂRRX Medical (sold to Covidien), Conor Medsystems (IPO; sold to Johnson & Johnson), and Pharmaca Integrative Pharmacy. Bijan holds an A.B. in Molecular Biology from Princeton University, an M.D. and Master’s in Science in Healthcare Policy from Columbia University, and an M.B.A. from Harvard Business School. He is also a graduate of the Kauffman Fellows Program and has been published in several peer-reviewed journals.
Follow Bijan Salehizadeh:
About NaviMed Capital: NaviMed Capital is a Washington-DC based lower-middle market growth buyout firm focused on healthcare.
Nancy Satur
Medical Director & Dermatologist of Curology
Nancy Satur, MD is a licensed physician and a board-certified dermatologist based in San Diego, CA. Dr. Satur completed her undergraduate studies at Pennsylvania State University, graduating magna cum laude, and received her medical degree from Jefferson Medical College in Philadelphia as part of a 5-year accelerated medical program. Following an internal medicine internship and a year of specialty training in pathology, Dr. Satur completed her residency in dermatology at Case Western Reserve University Hospital in Cleveland, Ohio, where she had the honor of serving as Chief Resident. Having practiced medicine in the San Diego area since 1984, Dr. Satur maintains membership in professional societies including the American Academy of Dermatology, the San Diego Dermatological Society, the American Telemedicine Association, and the American Acne and Rosacea Society. Highly regarded for her expertise and dedication in caring for her patients of all ages in her private practice in the San Diego area, Dr. Satur now enjoys helping patients across the country attain and keep healthy skin.
Follow Nancy Satur:
About Curology: Curology is a cosmetic company that provides actual prescription skincare customized for their skin and delivered to their door.
Xue Snow Ge
Sr. Director, Clinical Pharmacology of Nektar Therapeutics
Xue Snow Ge serves as the Senior Director of Clinical Pharmacology at Nektar Therapeutics. She also serves as an Advisor at Berkeley SkyDeck.
Follow Xue Snow Ge:
About Nektar Therapeutics: Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Sylvana Quader Sinha
Founder, Managing Director and CEO of Praava Health
Sylvana Q. Sinha is founder and CEO of Praava Health, a leading healthcare company focused on improving health outcomes and patient journeys in emerging markets, where 85% of the world lives but whose current systems typically prioritize profits over patients.
Since launching in 2018, Praava has become Bangladesh’s fastest-growing consumer healthcare brand, and was designated a 2021 World Economic Forum Technology Pioneer and 2020 Fast Company World Changing Idea and Developing World Technology. Praava has served more than 300,000 patients and is tripling growth each year. Throughout the COVID-19 pandemic, Praava quadrupled its patient base while maintaining an NPS rating of 91.3—significantly exceeding even the highest scores of Fortune 500 companies.
Sylvana also has decades of experience leading teams in international law, business, development, and government relations at major international law firms, management consulting firms, the World Bank, and think tanks in the Middle East and S. Asia. In addition to serving as an advisor to then-Senator Obama, she has independently advised private and sovereign clients on investments, projects, and disputes in the Middle East, Africa, and S. Asia.
Sylvana is a Life Member of the Council on Foreign Relations, a member of the World Economic Forum’s UHC2030 Private Sector Constituency, and served on Mount Sinai’s Arnold Institute of Global Health Task Force for Global Advantage. She is a graduate of Columbia Law School, Harvard’s Kennedy School, and Wellesley College and was a Visiting Scholar at the University of Oxford.
Follow Sylvana Quader Sinha:
About Praava Health: Praava Health is a patient-driven company disrupting the healthcare standard for Bangladesh’s 170 million citizens.
Peng Yin
Co-Founder, Director of NuProbe
Peng is a Professor in the Department of Systems Biology at Harvard Medical School. He also serves as a Core Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he co-founded Ultivue. Co-Founder, Director at Torus Biosystems.
Follow Peng Yin:
About Harvard Medical School, NuProbe, Torus Biosystems, Ultivue, Wyss Institute: An early stage molecular diagnostics company.
Ryan Bell
Marketing Director at Comcast SportsTech of Boomtown Accelerators
Ryan A Bell is recipient of the Presidential Award for his volunteer work with Special Olympics and the youth in Oakland. He is a writer for The Good Men Project and a branding/marketing specialist for companies of all sizes. He also happens to be the most connected man on Periscope.
Follow Ryan Bell:
About Boomtown Accelerators: Boomtown’s bespoke accelerator programs help startups turn ideas into profitable, scalable businesses.
Jose Vieitez
Co-Founder, Director and Portfolio Manager of Boomtown Accelerators
Follow Jose Vieitez:
About Boomtown Accelerators, The Farm Atlanta: Boomtown’s bespoke accelerator programs help startups turn ideas into profitable, scalable businesses.
Danielle White
CMO & Director of Marketing of Greyfinch
Danielle White is the Strategic Projects Manager at Rock Dental Brands.
Follow Danielle White:
About Greyfinch, Rock Dental Brands: Greyfinch is an orthodontic practice management software.
Rob Callaham
Product Manager & Director of Finance of Greyfinch
Rob Callaham is the Product Manager & Director of Finance at Greyfinch.
Follow Rob Callaham:
About Greyfinch: Greyfinch is an orthodontic practice management software.
Marie Auguste
Director of Materials Planning of Drive Medical
Marie Auguste joined Drive Medical in 2006 as Purchasing Manager. With over 20 years of experience in international business, Marie holds a Suny Maritime MBA in International Business and Trade. As a result of her leadership and dedication during the SAP implementation she was named Director or Materials Planning in 2009. Her primary responsibilities are not limited to but include data integrity, forecast and developing demand planning work processes in conjunction with Management & Commodity teams. Prior to joining Drive Marie held positions as a Production Manger for woven products at GAP International, and Purchasing Manager for Professional Audio products at Samson Technologies.
Follow Marie Auguste:
About Drive Medical, Premier: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Richard Burke
Non-Executive Chairman of the Board of Directors of UnitedHealth Group
Richard Burke is a Non-Executive Chairman of the Board of Directors at UnitedHealth Group.
Follow Richard Burke:
About : UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Robert Darretta
Member of the Board of Directors of UnitedHealth Group
Robert Darretta is a Member of the Board of Directors at UnitedHealth Group.
Follow Robert Darretta:
About : UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Josiane Peluso
Director, Medicare Sales and Marketing of UnitedHealth Group
Josiane Peluso is an Executive Director with a fortune 500 company. She’s been with the company for eleven years starting as a Health Education Specialist, progressively moving into different positions. Josiane received her Bachelor’s degree in Health Promotions from St. Francis College and a Masters in Community Health From Brooklyn College.
Follow Josiane Peluso:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Diane Gaswirth
Sales Director of UnitedHealth Group
Diane Gaswirth, B.S., M.S., is the sales director in San Diego county for UnitedHealthcare Medicare Solutions. She is responsible for growing membership in the Medicare portfolio of products. Prior, Diane was the sales manager for SecureHorizons/Pacificare and served in advertising, educational and service roles at Blue Cross of California. She also completed the Center of Excellence in Healthcare Management course through the University of Southern California.
Follow Diane Gaswirth:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Melanie Raslan
Senior Director, Member Analytics and Reporting of UnitedHealth Group
Melanie Raslan is Director of Marketing Analytics at UnitedHealthcare Group.
Follow Melanie Raslan:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
David Claiborn
Sr. Director, Product Design: Contact Center Services of UnitedHealth Group
Follow David Claiborn:
About UnitedHealth Group, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Andrew Flood
Director Data Science of UnitedHealth Group
Follow Andrew Flood:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Cheri Geraffo
National Account Director of UnitedHealth Group
Cheri Geraffo is part of the UnitedHealthcare Medicare and Retirement Innovation Team. Her work is primarily focused on projects that will benefit UnitedHealthcare members and their family caregivers.
Follow Cheri Geraffo:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Mike Hanson
Director of UnitedHealth Group
Mike Hanson has many years of experience with IT leadership, having managed several different aspects of technology over the past 30 years. Today, he serves as global operations manager and leads the asset management and fulfillment teams for Optum, Inc. He has been involved with HDI for many years, as both a local chapter officer and as a past chair of the HDI Desktop Support Advisory Board.
Follow Mike Hanson:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Cheri Geraffo
National Account Director of UnitedHealth Group
Cheri Geraffo is part of the UnitedHealthcare Medicare and Retirement Innovation Team. Her work is primarily focused on projects that will benefit UnitedHealthcare members and their family caregivers.
Follow Cheri Geraffo:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Mike Hanson
Director of UnitedHealth Group
Mike Hanson has many years of experience with IT leadership, having managed several different aspects of technology over the past 30 years. Today, he serves as global operations manager and leads the asset management and fulfillment teams for Optum, Inc. He has been involved with HDI for many years, as both a local chapter officer and as a past chair of the HDI Desktop Support Advisory Board.
Follow Mike Hanson:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
David Wang
Senior Managing Director of OrbiMed
Dr. David Wang is a Senior Managing Director, Asia. Most recently, he was a Managing Director at WI Harper Group, responsible for healthcare investment in China. Previously, he served as Head of Business Development at Siemens Medical Solutions, where he directed corporate strategy and new businesses in molecular diagnostics and diagnostic imaging. He was co-founder and EVP at First Genetic Trust, a personalized medicine company. During his tenure at Bristol-Myers Squibb, he was Chairman of The SNP Consortium Management Committee, the first group of its kind formed by pharmaceutical and technology industries to support the development of personalized medicine. He received his MD from Peking University Medical School. He earned his doctorate in Developmental Biology from California Institute of Technology.
Follow David Wang:
About OrbiMed: OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Ryan Loggie
Director of Accounting and Tax of OrbiMed
Follow Ryan Loggie:
About OrbiMed: OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Ilan Kaufthal
Director of Bio-Reference Laboratories
Ilan Kaufthal served as a Senior Advisor at Irving Place Capital from July 2008 to July 2013. Mr. Kaufthal has over 30 years of experience as an investment banker and senior corporate executive. He joined Irving Place Capital in 2008 and focused on retail and consumer products. He joined Bear, Stearns & Co. Inc. in May 2000 and served eight years there as the Vice Chairman of Investment Banking from May 2000 to July 2008. Mr. Kaufthal served as the Head of Mergers and Acquisitions as the Vice Chairman of Schroder & Co. for 13 years and a Managing Director from February 1987 to March 1997. He served as the Vice Chairman of Schroder & Co. Inc. from April 1997 to May 2000. He served at Schroder, and PROTEAM.com, Inc. He served as the Chief Financial Officer and Senior Vice President at NL Industries Inc. from May 1971 to February 1987. He served as the Chairman of East Wind Advisors, LLC since May 2011. Mr. Kaufthal has been a Director of Cambrex Corporation since 1983; and Blyth, Inc. since February 24, 2012. He serves as a Director of Edmunds.com, Inc. He serves as the Chairman of the American Friends of Bezalel. He serves as a Member of the Board of Visitors of Columbia University Medical Center. He serves as a Member of the Trustee Council of The Jewish Museum, Ramaz School in New York City and The Russell Berrie Foundation. He serves as a Non-Management Director of Fairfield Resorts, Inc. and Wyndham Vacation Resorts, Inc. He serves as a Director of Cambrex Profarmaco Landen N.V. He has been a Director of Bio-Reference Laboratories Inc. since March 3, 2015. He has been Director of Quinpario Acquisition Corp. 2 since November 2014. He has been a Director of Tronox Limited since June 15, 2012. He served as an Independent Director of Jason Industries, Inc. from August 2013 to June 30, 2014. He served as Director of PROTEAM.com, Inc. He served as a Director of Phytomedics, Inc. since August 2006, ASI Solutions, Inc. since joining in 1996, United Retail Group, Inc. from December 1992 to November 8, 2007, and Kid Brands, Inc. (alternate name, Russ Berrie & Co. Inc.) from 1995 to August 2006. He served as a Member of the Advisory Board of Gemini Israel Funds and Jerusalem Venture Partners Media Fund. Mr. Kaufthal holds an M.B.A. Degree from the New York University Graduate School of Business Administration and a B.A. from Columbia University.
Follow Ilan Kaufthal:
About Bio-Reference Laboratories: BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing .
Amy Labroo
Director, Digital Marketing & OmniChannel of GSK
Follow Amy Labroo:
About GSK: GSK Venture Fund is a Massachusetts-based venture capital fund focused on investments within the area of bioelectronics.
Scott Marshall
Managing Director of Precision Analytics of Precision for Medicine
Scott Marshall is the Managing Director, Provide Technology Driven Biomarker Data Integration & Computational Biology at QuartzBio.
Follow Scott Marshall:
About Precision for Medicine, Quartz Bio: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Daniel Birtwhistle
Senior Director Product Development Security of GE Healthcare
Follow Daniel Birtwhistle:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Mindy Zhang
Director of Product Management of Oscar Health
Follow Mindy Zhang:
About First Round Fast Track, Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Joshua Long
Director of Design of Oscar Health
Follow Joshua Long:
About Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Anaf Durrani
Senior Director of Cigna
Anaf Durrani has been with Cigna since 2013 and is currently responsible for leading the DevOps and Productivity Engineering Center of Enablement and the Software Defined Everything (SDx) initiative for Global Infrastructure Services. In this role, Anaf drives DevOps architecture, engineering, and enablement working across 500 scrum teams. As the SDx lead, Anaf is bringing a software engineering mindset to infrastructure to enable Cigna to support a hybrid, multi-cloud environment. Anaf started his career at Motorola in the Push-to-Talk (PPT) division as an engineer. He was part of a team that expanded PTT globally. Prior to Cigna, Anaf spent 6 years at Orbitz.com and its online retail travel brands leading Product Development and Quality Engineering organizations transitioning his teams to practice continuous delivery. Anaf has worked in the business and IT with a primary focus on enhancing customer experience. His experience with start-ups and enterprise development provides a unique experience to enable transitions. Anaf has earned a master’s in software engineering from Southern Methodist University, a bachelor’s in computer science from DePaul University and currently resides in Schaumburg, IL with his wife, 3 sons and 2 daughters.
Follow Anaf Durrani:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
James Rogers
Member of the Board of Directors of Cigna
James Rogers is Chairman of the Board of Directors at Duke Energy. Prior to being elected Chairman of the Board of Directors in January 2007, James also served as Duke Energy’s President and Chief Executive Officer from April 2006 until his retirement on July 1, 2013. Rogers served as a Chief Executive Officer in the utility industry for 25 years. Over that period, James delivered an average total shareholder return of more than 12 percent per year by focusing on sustainable growth and executing a series of well-timed mergers, acquisitions and divestitures. In 2013, James was awarded the Edison Electric Institute’s Distinguished Leadership Award by his industry peers in recognition of his 25 years of service and exemplary contributions to the electric utility industry. In addition, the Alliance to Save Energy honored Rogers with its Lifetime Achievement Award. James became President and Chief Executive Officer at Duke Energy following the merger between Duke Energy and Cinergy in 2006. Before the merger, James served as Cinergy’s Chairman of the Board of Directors and Chief Executive Officer for more than 11 years. Prior to the formation of Cinergy, James joined PSI Energy in 1988 as the company’s Chairman of the Board of Directors, President and Chief Executive Officer. James has served as Deputy General Counsel for Litigation and Enforcement for the Federal Energy Regulatory Commission (FERC); Executive Vice President of Interstate Pipelines for the Enron Gas Pipeline Group; and as a Partner in the Washington, D.C., law office of Akin Gump Strauss Hauer & Feld. Prior to those appointments, James served as Assistant to the Chief Trial Counsel at FERC; as a Law Clerk for the Supreme Court of Kentucky; and as Assistant Attorney General for the Commonwealth of Kentucky, where he advocated for the state’s consumers in gas, electric and telephone rate cases. James was also a Reporter for the Lexington (Kentucky) Herald-Leader for three years. In the course of his career, James has served on the boards of directors of eight Fortune 500 companies and is currently a Member of the Board of Directors at Cigna Corp. and Applied Materials Inc. In 2010 and 2011, James was named by the National Association of Corporate Directors’ Directorship magazine to its annual Directorship 100, recognizing the most influential people in corporate governance. Also during his career, he has owned and/or operated assets in 17 countries in Africa, South Asia, Europe, and Central and Latin America. Born in 1947 in Birmingham, Ala., James grew up in Kentucky. James attended Emory University and earned Bachelor of Business Administration and Juris Doctor degrees from the University of Kentucky, where he was a Member of the Kentucky Law Journal and Beta Gamma Sigma National Honor Society. James was named to the Hall of Fame at the Carol Martin Gatton College of Business and Economics and the Hall of Fame at the College of Law, both at the University of Kentucky. James was inducted into the University of Kentucky’s 2010 Hall of Distinguished Alumni. James has also been awarded Honorary Doctorate degrees from four universities. James and his wife, Mary Anne, have two daughters, a son and 11 grandchildren.
Follow James Rogers:
About : CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Ian Van Every
Co-Founder & UK Managing Director of Lemonaid Health
Follow Ian Van Every:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Lawrence Olanoff
Member of the Board of Directors of Ironwood Pharmaceuticals
Lawrence Olanof is a Special Advisor to the President for Corporate Relations at MUSC. After a long career in the pharmaceutical industry, Lawrence retired from his last position as President and Chief Operating Officer (2006-2010) at Forest Laboratories, Inc., and served as a Member of the Board of Directors at Forest Laboratories, Inc. until 2014. Lawrence is currently a Member of the Board of Directors at Ironwood Pharmaceuticals Inc. and Axovant Sciences Ltd. Lawrence also serves as a Member of the Non-Profit Boards of the Institute for Applied Neurosciences at the Medical University of SC, the Clinical Biotechnology and Research Institute at Roper St. Francis Hospitals and the Horizon Development Project; is a Member of the Advisory Board of BioMotiv and is an ex-officio Member of the MUSC Foundation for Research Development Board. In these affiliations, Lawrence is actively involved in advising companies and non-profit institutions in areas of drug discovery and development. Lawrence was President and Chief Executive Officer of Celsion Corporation from 2005 to 2006. From 1995 until 2005, Lawrencef was responsible for the leadership of research and development activities for Forest Laboratories, Inc., ultimately as its Executive Vice President-Scientific Affairs. From 1993 to 1995, Lawrencef was Senior Vice President-Clinical Research and Development at Sandoz Pharmaceutical Corporation. From 1984 to 1993, Lawrence was employed by The Upjohn Company, where his last position was Corporate Vice President-Clinical Development and Medical Affairs. Lawrence holds M.D. and Ph.D. (Biomedical Engineering) degrees from Case Western Reserve University and was a medical resident and clinical pharmacology fellow at MUSC. Lawrence also holds M.S. degree in Biochemical Engineering from Rutgers University and B.S. degree in Chemical Engineering from Tufts University. Lawrence is the Author or Co-Author of numerous scientific publications in the fields of clinical pharmacology, drug delivery and pharmacokinetics. During his industry career, Lawrence was involved in the approval of some 30 new drugs, new indications or novel formulations in the US.
Follow Lawrence Olanoff:
About : Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Marsha Fanucci
Member of Board of Directors & Audit Committee Chair of Ironwood Pharmaceuticals
Marsha H. Fanucci has been a director since March 2005. Ms. Fanucci served as Senior Vice President and Chief Financial Officer of Millennium Pharmaceuticals, Inc., a biopharmaceutical company, from July 2004 through January 2009, where she was responsible for corporate strategy, treasury, financial planning and reporting and operations. While at Millennium since 2000, she also served as Vice President, Finance and Corporate Strategy and Vice President, Corporate Development. (Millennium was acquired by Takeda Pharmaceutical Company Limited in May 2008 and is now Millennium: The Takeda Oncology Company). Ms. Fanucci is a member of the board of directors of Alnylam Pharmaceuticals, Inc. and Ironwood Pharmaceuticals, Inc. She received her B.S. in pharmacy from West Virginia University and her M.B.A. from Northeastern University. Ms. Fanucci’s qualifications to sit on the board include her expertise with public and financial accounting matters, including her experience leading financial organizations in biotechnology companies.
Follow Marsha Fanucci:
About : Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Daniel Grau
President, Chief Executive Officer, and Director of Sojournix
Grau co-founded and has served as Chief Executive Officer and Director at Sojournix since 2016. An experienced biotech entrepreneur and operating executive, Mr. Grau led the deal to acquire SJX-653 and has driven the rapid growth and financing of the company from startup to clinical-stage pharmaceutical business. Prior to Sojournix, Mr. Grau served as President at Heptares Therapeutics (acquired 2015), Chief Executive Officer at Cortria (acquired 2010), and Chief Operating Officer at CombinatoRx (IPO 2005). Mr. Grau currently serves as an advisor to HotSpot Therapeutics and previously served as a member of the Product Advisory Board at Concert Pharmaceuticals and as an advisor to Nimbus Therapeutics. Earlier in his career, Mr. Grau worked with multi-national pharma companies as a management consultant focused on corporate and business franchise strategy, M&A, and new product launches. Mr. Grau earned his M.Phil., M.A., and M.A.R. degrees from Yale University, where he was awarded a Mellon Fellowship, the Day Graduate Prize, and a Bass Fellowship, and a B.A. with High Honors from Davidson College, where he held a Dana Honor Scholarship, a Montgomery Scholarship, and was elected to Phi Beta Kappa.
Follow Daniel Grau:
About Cortria Corporation, Heptares Therapeutics, Sojournix: Sojournix is a biotechnology company developing innovative medicines for women’s health and endocrine disorders.
Carson Pickens
Executive Director, Product Management of Aetna
Carson Pickens is the Executive Director of Digital Product Management at Aetna, a CVS Health Company. In this capacity, he and his team are responsible for the consumer facing assets that Aetna puts in the hands of its members. Prior to joining CVS Health, Carson was the Chief Product Officer at HealthEngine, a Chicago based start-up focused on reducing healthcare costs for patients. Earlier in his career, Carson was an early employee at bswift, a benefit administration and enrollment company acquired by Aetna in 2014. At bswift, he served in a number of leadership roles in operations and product management.
Follow Carson Pickens:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Aleksandar Lazarevic
Senior Director of Aetna
Aleksandar is responsible for overall predictive analytics solution in health care fraud initiative at Aetna. In addition to health care industry, he has extensive experience in various data analytics projects ranging from banking, credit and insurance industry to diagnostics and computer security applications. He has co-edited a book on cyber security threats, written 8 book chapters and published over 50 research articles, which were cited more than 3,000 times. He holds a PhD degree in data mining / machine learning from Temple University. He had been frequently giving presentations at predictive analytics / data mining conferences in the past.
Follow Aleksandar Lazarevic:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Kristie Parr
Executive Director, Marketing Technology and Digital Operations of Aetna
Follow Kristie Parr:
About Aetna, Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Mark Feuer
Independent Non-Executive Director of Constellation Healthcare Technologies
Feuer is the founding partner of Beechwood Capital Group, a private investment firm located in New York, which is focused on investments in the healthcare and insurance industries. Prior to forming Beechwood, Feuer most recently was Chief Executive Officer of Marsh USA. In previous roles he was also the Chief Operating Officer of Merrill Lynch Americas, with responsibility for the Trust Company, Retirement Division, Private Bank, and other operations. Feuer sat on the Product Development committee for the Global Wealth Management organisation. Feuer serves on several Boards of Directors, including many non-profit institutions in the New York area. He holds a Juris Doctor from New York Law School and an LLM in Taxation from New York University School of Law.
Follow Mark Feuer:
About : Constellation Healthcare Technologies provides a holistic, integrated suite of practice management support services to hospitals.
Michael LaVance
Director & Business Development of Lively
Michael LaVance is the Director & Business Development at Lively.
Follow Michael LaVance:
About Lively: Lively is a modern Health Savings Account (HSA) platform for employers and individuals.
Irene Esteves
Member of the Board of Directors of Aramark
Irene Esteves has been a member of the Board since October 2014. Irene is an experienced public company executive, having served most recently as Chief Financial Officer of Time Warner Cable Inc. from July 2011 to May 2013. Prior to that position, Irene served as Senior Vice President and Chief Financial Officer of Regions Financial Corporation from April 2008 to February 2010. Irene is currently a member of the Board of Directors of Aramark and Spirit Aerosystems Holdings, Inc. and previously served on the Board of Directors of Timberland Co., Johnson Diversey Inc. and tw telecom. Irene is a member of the Audit Committee.
Follow Irene Esteves:
About : Aramark provides food services, facilities management, and uniform and career apparel to healthcare institutions and more.
Tyler Geopfert
Director Of Business Development-Higher Education-West of Aramark
Follow Tyler Geopfert:
About Aramark, Griffin Company Realtors, TrackWired: Aramark provides food services, facilities management, and uniform and career apparel to healthcare institutions and more.
Donovan Pepper
National Director, Local Goverment Relations of Walgreens
Donovan is the National Director of Local Government Relations for Walgreen Co. Prior to this position, Donovan served as the Director of Government Relations for the Illinois Restaurant Association. He has worked for SBC, the Chicagoland Chamber of Commerce, and served on the Appropriations in Political Studies from Univ. of Illinois-Springfield and a Bachelor’s in Political Science from Sangamon State.
Follow Donovan Pepper:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Abey Koshy
Director of Data & Corporate Technologies ,Principal Architect of Walgreens
Abey Koshy is the Director of Data & Corporate Technologies ,Principal Architect at Walgreens.
Follow Abey Koshy:
About Walgreens, Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Kurt Erchinger
Sr. Director, Online Technology, Digital Engineering & Mobile Solutions of Walgreens
Kurt Erchinger is the Sr. Director, Online Technology, Digital Engineering & Mobile Solutions at Walgreens.
Follow Kurt Erchinger:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Kurt Erchinger
Sr. Director, Online Technology, Digital Engineering & Mobile Solutions of Walgreens
Kurt Erchinger is the Sr. Director, Online Technology, Digital Engineering & Mobile Solutions at Walgreens.
Follow Kurt Erchinger:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Regan Wynne
Senior Director, Brand Marketing and Communications of TigerConnect
Extensive strategic B2B experience marketing Healthcare IT products, Internet of Things solutions, general IT services, augmented reality hardware & software, and other cutting-edge technologies. Over two decades of driving leads and conversions for a variety of companies from startup and early growth through ramp-up and expansion. Diverse background leading, developing, and executing strategies that build the marketing/sales funnel including content marketing, digital marketing, public relations, brand positioning, and thought leadership.
Follow Regan Wynne:
About TigerConnect: TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.
Maren Ohaks Katzaroff
Director – Strategic Planning of Vivos Inc
Maren drives the commercialization of AMI’s brachytherapy products including operational and regulatory aspects through strategic initiatives. Maren has extensive expertise in global commercialization strategies, operations, strategic planning and regulatory compliance in a variety of sectors including medical device, biotechnology, academia and banking. Maren has been instrumental in preparing device and drug products for FDA review including quality system establishment, manufacturing oversight, preparation of FDA filings and participation in FDA reviews. Prior to joining AMI, Maren was employed by the University of Washington (UW) to create and run programs to facilitate engagement between industry and UW researchers and students to foster commercialization of UW technology. This included opening and running the first UW managed high tech incubator. In addition, Maren has held key strategic and operational roles for a number of medical device and biotechnology companies including Amgen and several Seattle area start-ups. She earned an MBA with an emphasis in Management and Technology, and a BS in Cell and Molecular Biology with a minor in Chemistry, both from the UW. Maren enjoys active roles in numerous community organizations.
Follow Maren Ohaks Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Donald A. Ludwig
Director of Special Projects of Vivos Inc
Donald A. Ludwig, PhD., is Director of Special Projects for AMI. As an expert in particle accelerator applications in radiation therapy, nuclear medicine and radioisotope production Dr. Ludwig also serves as an advisor to numerous entities in the field, both domestic and foreign. Among these are the Atomic Energy of Canada, the U. S. Department of Energy Labs at Los Alamos, Berkeley, Fermi, Hanford and Oak Ridge, the Israel Atomic Energy Agency, the Australian Nuclear Science and Technology Organization, the Budker Institute of Nuclear Physics in Novosibirsk, Siberia, the Malaysian Institute of Nuclear Technology and the Bhabha Atomic Research Center in Mumbai, India. He holds advanced degrees in nuclear physics, medical physics and marketing from top tier Universities. Dr. Ludwig’s endeavors for AMIC are focused on facilitating the return of clinical radioisotope production to the US, and aiding AMIC in becoming the largest provider of radioisotopes in North America.
Follow Donald A. Ludwig:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Bret Henning
Sr Director and Information Technology of Tandem Diabetes Care
Bret Henning is currently the Sr. Director of Information Technology at Tandem Diabetes Care, Inc. Bret is responsible for worldwide IT operations including infrastructure, cloud computing, collaboration technologies, enterprise applications, DEVOPS, call center and voice technologies. At Tandem Bret was involved in building the company from an early stage startup through product commercialization. He brings a diverse portfolio of experience managing everything from Facilities to Connected Heath. His background includes more than 30 years of hands-on experience in technology for electronics and medical device companies.
Follow Bret Henning:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Caleb Winder
Managing Director of Excel Venture Management
Caleb Winder is a venture capitalist who focused on life sciences, healthcare and information technology. He is currently a Managing Director at Excel Venture Management & at the MemorialCare Innovation Fund Caleb has a broad set of experiences from his early career in sales and marketing at small and medium sized companies in the diagnostics and medical capital equipment business and from his work in marketing, business development, and finance at various startups. Caleb currently serves on the boards of ClearDATA, Aileron Therapeutics, InfoBionic, WellDoc, Ayogo Health, and Qstream. He formerly served on the boards at Cleveland Heartlab, MedVentive, Saladax, ShapeUp, Oculus Health, Aventura, and Xcellerex
Follow Caleb Winder:
About AristaMD, Excel Venture Management, Excel Venture Management, Foldax, Laudio, LeanTaaS, MemorialCare Innovation Fund, Olive, Phynd Technologies, Xealth: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Juan Enriquez
Managing Director of Excel Venture Management
Juan Enriquez is a Managing Director at Excel Venture Management. He is a leading authority on the economic impact of life sciences on business and society, and a respected business leader and entrepreneur. He represents Excel on the boards of Shape Up the Nation, Fina Technologies, Catch.com, and Synthetic Genomics, as well as Activate Networks. Prior to Excel, Enriquez was the Founding Director of the Harvard Business School’s Life Sciences Project, with many of his innovative thoughts captured in his bestselling book, As the Future Catches You, which provides an accurate blueprint of how a bio-based economy changes industries and corporations. Following HBS, Enriquez became an active angel investor and founder of Biotechonomy Ventures, which invested in BioTrove, Xcellerex, and Synthetic Genomics, a company he co-founded with Drs. J. Craig Venter and Hamilton Smith, to apply life sciences to energy markets. As a business leader, advisor, and renowned speaker, he works directly with the CEOs of a number of Fortune Fifty companies, as well as with various heads of state, on how to adapt to a world where the dominant language is shifting from digital towards the language of life. He is a member of the Board of Directors of Cabot Corporation (NYSE: CBT), and he graduated from Harvard with a B.A. and M.B.A., both with honors.
Follow Juan Enriquez:
About Biotechonomy, Excel Venture Management, Viridos: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Rick Blume
Managing Director of Excel Venture Management
Rick Blume has been financing companies in healthcare for over three decades. His early investment banking career involved financing and banking relationships with hospitals, payers, physicians, and new biotech companies. The excitement he saw at Genentech, in its early years, led him to transition into venture capital in the mid 1980’s. Rick co-founded CB Health Ventures in 1998 where he assembled what is now the core of Excel including Enrico Petrillo, M.D., Steve Gullans, PhD, and Tricia Moriarty. Rick has served as a director or active investor in many companies including Lantos Technologies, Cytyc (acquired by Hologic – HOLX), AbT (now OSI – OSIP), Somatogen (acquired by Baxter – BAX), EdenTec (acquired by Nellcor), Exact Sciences (EXAS), IPC The Hospitalist Company (IPCM), GeneOhm (acquired by Becton Dickinson – BDX), Zonare, TransMedics, US Servis (acquired by McKesson); and the former public health insurance company Washington National. In addition to Excel, Rick has been active in initiating and teaching courses in venture capital and entrepreneurship at both Boston College Carroll School of Management and Simmons College School of Management, and serving on the Boards of the Chicago Biomedical Consortium and the National Regenerative Medicine Foundation .Rick did his undergraduate studies at University of the Pacific and Stanford. His MBA is from Stanford University.
Follow Rick Blume:
About CB Health Ventures, Excel Venture Management, GeneOhm Sciences, Zonare Medical Systems: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Tad Buchanan
Director of Fabric Genomics (formerly Omicia)
Mr. Buchanan co-founded the investment firm of Buchanan Investments, Inc. in 1998 with his father, Mike. Together, they have founded, invested in and raised equity and debt capital for numerous companies, including DM&E Railroad, Central Montana Resources, Opti Canada, White Oak Resources, AlphaClone, TabletCommand, Gensys Software, Tri Alpha Energy, OneSun Solar, and numerous other private companies. Prior to founding Buchanan Investments, Inc., Tad was an Executive Director at UBS Securities with primary responsibility for managing Asian equity sales and trading based in NY. He was also an equity analyst at UBS and W.I. Carr (Far East), Ltd. based in Hong Kong, with responsibility for covering financial services, software, industrial and energy companies in Indonesia, Thailand, India, Pakistan, Sri Lanka and Bangladesh. Prior to joining W.I. Carr (Far East) Ltd., Tad was a credit analyst within the Corporate Lending Group of Wells Fargo Bank. He graduated from Pepperdine University with a B.A. in Economics and from Boston College with an M.B.A, International Finance. He currently serves on the boards of Central Montana Resources, AlphaClone, Tablet Command, and OneSun Solar. Tad is also a board observer of Tri Alpha Energy. He is married with three children, and is a Trustee of Marin Country Day School in Corte Madera, CA.
Follow Tad Buchanan:
About Fabric Genomics (formerly Omicia): Global healthcare platform for genomics-driven precision medicine. Fabric’ proven AI algorithms power genomic insights.
Jonathan Zhao
Founder & Managing Director, Asia of Veritas Genetics
Jonathan Y. Zhao, Ph.D. is Co-Founder of Veritas Genetics and serves as its Managing Director of Asia. Jonathan Zhao is responsible for Asia strategy and new products at Amgen and Pfizer. He holds MBA from MIT Sloan and Ph.D. in Chemistry.
Follow Jonathan Zhao:
About Veritas Genetics: Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer.
James Leonard
Director, Customer Services of Emory University
Follow James Leonard:
About Emory University: Emory University is an institute of higher learning and a private research university.
Stanley Lapidus
Board of Directors of Daktari Diagnostics
He is an experienced entrepreneur. He founded and served as CEO of three public companies, Cytyc, EXACT Sciences, and Helicos BioSciences. He currently serves as CEO of SynapDx Corp., which he founded in 2009 to develop novel diagnostics for autism. He teaches at the Biomedical Enterprise Program at MIT and is the inventor of 31 US patents.
Follow Stanley Lapidus:
About University of Colorado Anschutz Medical Campus: Daktari Diagnostics manufactures diagnostic medical products for clinicians and patients.
Paul Bernard
Director of Amazon Alexa Fund
Paul Bernard is the Director, Worldwide Corporate Development – Alexa Fund Lead at Amazon.
Follow Paul Bernard:
About Amazon, Amazon Alexa Fund: Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health.
John Gavin
Member of the Board of Directors of Varonis Systems
John Gavin has served as one of our directors since March 2010. From January 2007 to June 2008, Gavin served as Chief Financial Officer of BladeLogic, Inc., a provider of data center automation software, which was acquired by BMC Software, Inc. Prior to joining BladeLogic, Gavin served as the Chief Financial Officer for NaviSite, Inc., a provider of information technology hosting, outsourcing and professional services, from April 2004 through January 2007. Gavin has served on the board of directors of Cimpress N.V. (formerly known as Vistaprint, Inc.) since 2006, Qlik Technologies, Inc. since February 2010 and Varonis Systems, Inc. since 2013.
Follow John Gavin:
About : Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Snir Ben Shimol
Executive Director of Varonis Systems
Snir is the Head of Cyber Security at Varonis, leading the security research, forensics and incident response teams. Snir began his career in the IDF Technology and Intelligence unit and continued as a Security Researcher in the Israeli Prime Minister’s Office. Since then, he has worked in the Advanced Security Center of EY as the Cyber Security Advisory leader, managing red-team operations and risk assessments. He has advised major international corporates and high-profile individuals to build their security resilience and protect their organization. Prior to his current role, he led Radware’s Cyber Security Research division, responsible for innovation and security solution capabilities.
Follow Snir Ben Shimol:
About Varonis Systems: Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Robert Sobers
Director of Inbound Marketing of Varonis Systems
Follow Robert Sobers:
About Varonis Systems: Varonis Systems provides actionable data governance solutions for financial services, healthcare, energy, manufacturing and tech companies.
Ed Hammond
Director of Clinical Programs of Domain Surgical
Ed Hammond is the Director, Clinical Programs at OmniGuide.
Follow Ed Hammond:
About Domain Surgical, OmniGuide: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Jason Klarreich
Managing Director, CFO, COO, & CCO of JW Asset Management
Jason Klarreich is the managing director, CFO, COO, and CCO at JW Asset Management. Before joining JWAM, Jason was a director and trader at Heartland Securities. He previously worked in fixed income sales at Morgan Stanley and at Smith Barney as a financial analyst in the asset management division. Jason serves on the board at Arbor Pharmaceuticals. He graduated from Emory University with a bachelor’s degree in finance.
Follow Jason Klarreich:
About JW Asset Management: JW Asset Management is a New York-based investment firm that primarily invests within the healthcare sector.
Tami D Schafer
Director of Process Improvement & Implementation of Omega Healthcare
Tami has 35 years of experience and proven success in the managed healthcare and insurance industry, as well as private consulting. Her most recent focus has been in the areas of operational process improvements and new client, product and/or program implementations. Her expertise in Client Relations, Customer and Provider Relations and Network Development have contributed toward her strong ability to identify and document operational opportunities for improvement, creative problem resolution, and promote effective relationships with both internal and external customers. Her operational expertise and strong leadership abilities have enabled her to work with cross-functional units to successfully facilitate and lead new client, product and/or program implementations from start to launch.
Follow Tami D Schafer:
About Omega Healthcare: Omega Healthcare, a front-runner in the healthcare service space in India.
Seth Rodner
Founding Partner & Managing Director of Dermarche Labs
Seth Rodner is a founding partner and a Managing Director of Dermarché Labs, where he serves as Chief Operating Officer and Chief Legal Officer, overseeing the company’s enterprise-wide business operations, legal affairs, government affairs, and corporate compliance. Prior to co-founding Dermarché Labs,Rodner acquired a unique combination of government, private law practice, and public company executive experience spanning a 20-year legal and business career. He has served as a federal prosecutor with the U.S. Department of Justice in Washington, D.C., where he specialized in international cartel enforcement; an equity partner in a prominent Florida law firm, where his nationwide practice focused on government investigations, regulatory proceedings, complex business disputes, and board counseling in highly-regulated industries including healthcare and life sciences; and most recently as Executive Vice President, Chief Legal Officer & Corporate Secretary of Medicis Pharmaceutical Corp. (NYSE: MRX), where he was appointed by the Board of Directors as a Section 16 executive officer. Rodner initially joined Medicis in 2006 as its first Chief Compliance Officer, in which capacity he architected the company’s award-winning compliance program in a strategic way that allowed Medicis to achieve best-in-class status while simultaneously fueling the launch and growth of the largest dermatology franchise in the world. In 2010, he was appointed by the Medicis Board to assume firm-wide responsibility for the corporation’s legal affairs with a broad mandate including all corporate governance, securities disclosure, FDA regulatory, transactional, litigation, contracting, and intellectual property matters. During his legal tenure,Rodner led the evaluation, negotiation, and patenting of numerous substantial technology licensing arrangements; advised the U.S. and international regulatory approval and commercial launch of numerous reimbursed and unreimbursed prescription pharmaceuticals, Class III medical devices, and biologics; and guided the $455 million acquisition of Graceway Pharmaceuticals in 2011, representing the then-largest transaction in Medicis’s history; the Company’s $500 million convertible senior notes offering in 2012 with associated hedge and warrant transactions; as well as Medicis’s $2.6 billion acquisition by Valeant Pharmaceuticals in 2012, representing a 40% premium to Medicis shareholders. Rodner earned a B.A. from Amherst College and a J.D. from Duke University School of Law.
Follow Seth Rodner:
About Dermarche Labs: Dermarche Labs is a clinically advanced line of fast-acting rejuvenation treatments.
Andrew Schiff
Managing Director of Aisling Capital
Schiff joined Aisling in September of 1999 and currently serves as one of the Managing Partners. Prior to Aisling Capital, Dr. Schiff practiced internal medicine for six years at The New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine. Dr. Schiff currently serves as a director of Agile Therapeutics, ARMGO Pharma, PowerVision and ZELTIQ Aesthetics. Prior Board service includes Adams Respiratory Therapeutics, ArgiNOx Pharmaceuticals, Barrier Therapeutics, Bioenvision, CardioKine, Cempra Pharmaceuticals, Miramar Labs, Myogen, SkinMedica, Sirion Therapeutics, TransEnterix and Quintiles (Board observer). He is a longtime supporter and Board member of the Visiting Nurse Service of New York. Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia University, and his B.S. with honors in Neuroscience from Brown University.
Follow Andrew Schiff:
About Aisling Capital: Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by
Jeffrey Gatz
Director of BioIVT
Jeffrey Gatz is the director at BioIVT.
Follow Jeffrey Gatz:
About : BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Alex Milligan
Co-founder & Marketing Director of Nugg
Follow Alex Milligan:
About Nugg: Nugg allows mmj patients to find and order cannabis-based products from nearby collectives that deliver or offer pickup.
Doug Russell
Managing Director and Head of MassMutual Ventures of MassMutual Ventures
Follow Doug Russell:
About MassMutual Ventures: MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health.
Michael Bartholomew
Co-Founder, Inside Director & Chief Commercial Officer of Promaxo
Mr. Michael Bartholomew is the EVP and Chief Commercial Officer at Promaxo. He has broad therapeutic experience across nearly twenty diseases covering large and small molecules, medical devices and diagnostics. Michael manages the go to market strategy, voice of customer, partner relationships and tactical implementation relating to corporate infrastructure. Prior to Promaxo, Michael was a Principal at Porzio Life Sciences, as well as Vice President of Sales & Marketing for Dohmen Life Science Service, where he developed and launched several commercial initiatives achieving sustained sales growth. Before Dohmen, he served in various sales and brand leadership positions for Pfizer, Pharmacia and Baxter. Michael proudly served in the US Air Force as a decorated combat aviator, where he achieved the rank of Captain. He received his Masters of Science in Administration from Central Michigan University and his Bachelor of Arts in Economics from Indiana University.
Follow Michael Bartholomew:
About Neuro42, Promaxo: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Mark Bakken
Founder, Managing Director of HealthX Ventures
Mark Bakken is the Founder and Managing Partner at HealthX Ventures.
Follow Mark Bakken:
About Creative Destruction Lab (CDL), Cultivation Capital, HealthX Ventures: Madison, WI based venture fund focusing on seed stage investments in digital health companies
